« back

Dementia Consortium – Novel targets drug discovery

  Wednesday, 29 Jan 2020 | Funding Deadline

The Dementia Consortium is looking for novel targets in the areas of neurodegeneration and dementia generated by scientists at academic institutions in the UK and the rest of the world. The Consortium support target validation studies: preclinical research that aims to give confidence in the relevance of a novel target to a disease. The approaches can cover all aspects of dementia therapy, from treating the underlying pathology to improving cognition and other mental symptoms. The targets will be early stage, but should have some supporting data to support their role in disease; for example, based on population disease association studies, siRNA and rescue studies, or transgenic animal studies.

The research projects supported are collaborative in nature, with involvement from the Consortium members in devising the final project plan.

Deadline for proposals: 29th January 2020

Find out more here